Skip to main content
. 1999 Dec 1;19(23):10417–10427. doi: 10.1523/JNEUROSCI.19-23-10417.1999

Fig. 2.

Fig. 2.

UCP2 in extrahypothalamic limbic sites.A1–C2, Light micrographs reveal the expression of UCP2 immunoreactivity in extrahypothalamic limbic sites. These areas included the bed nucleus of the stria terminalis (BNST; A1,A2), the central nucleus of the amygdala (CeA; B1,B2), and the thalamic paraventricular nucleus (tPV; C1,C2). The higher power magnifications (A2,B2, C2) demonstrate the robust expression of UCP2 in neuronal processes in each of these areas. Scale bars: A1, 100 μm; A2, 25 μm.